Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Neurogenic Overactive Bladder (Study 515)
NCT00311376Phase 3Completed
- Sponsor
- Allergan
- Start
- Aug 2006
- Primary completion
- May 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 14
01
Overview
A Phase 3 trial of onabotulinumtoxinA in Neurogenic Bladder (NB), sponsored by Allergan. Started Aug 2006; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
Neurogenic Bladder (NB)
Beyond the preview
Go deeper on NCT00311376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00311376.